Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Gastrointest Endosc. 2016 Jan;83(1):201-8. doi: 10.1016/j.gie.2015.06.058. Epub 2015 Aug 28.
Polyp size ≥ 1 cm triggers more frequent colonoscopic surveillance, yet size is typically based on subjective endoscopic estimates. We sought to compare contemporary assessments of polyp size by endoscopic estimation and pathology measurement.
Colonoscopy and pathology reports were reviewed from the 2012 medical records at a large institution. Only polyps resected in toto with both endoscopic estimates and pathology measurements were included. Pathology measurements were considered the criterion standard. Factors affecting endoscopic miscall rates were assessed by multivariate analyses.
From 6067 polyps resected, both endoscopic and pathology sizes were available on 1528. Distribution of polyp size appraised by endoscopy but not by pathology revealed modal clustering, particularly around 1 cm. Among 99 polyps endoscopically called 1 cm, 72% were <1 cm on pathology. Of all 222 polyps estimated as ≥ 1 cm on endoscopy, 46% were <1 cm on pathology; of 1306 polyps estimated as <1 cm, 3.9% were ≥ 1 cm on pathology. By histology, 39% of adenomatous, 59% of sessile serrated, and 73% of hyperplastic polyps were overcalled; P = .008. By configuration, 34% of pedunculated, 49% of sessile, and 61% of flat polyps were overcalled; P = .014. Endoscopic overestimation was more common in women (54%) than in men (40%) (P = .03) and with proximal (56%) than distal (40%) sites; P = .02. Miscall rates were unaffected by endoscopist covariates.
Substantial discordance exists between endoscopic and pathology-based assessments of polyp size. Almost half of polyps called advanced on endoscopic estimates of size ≥ 1 cm fell below this threshold on actual pathology measurements.
息肉大小≥1cm 会触发更频繁的结肠镜监测,但大小通常基于主观的内镜评估。我们旨在比较当前通过内镜估计和病理测量评估息肉大小的方法。
回顾了一家大型机构 2012 年的病历中的结肠镜检查和病理报告。仅纳入了完整切除的息肉,这些息肉既有内镜估计,又有病理测量。病理测量被视为金标准。通过多变量分析评估影响内镜误诊率的因素。
在切除的 6067 个息肉中,有 1528 个息肉既有内镜大小又有病理大小。内镜评估但病理检查未发现的息肉大小分布呈模态聚类,尤其是在 1cm 左右。在 99 个内镜诊断为 1cm 的息肉中,72%在病理上<1cm。在所有 222 个内镜估计为≥1cm 的息肉中,46%在病理上<1cm;在 1306 个估计为<1cm 的息肉中,3.9%在病理上≥1cm。根据组织学,39%的腺瘤性息肉、59%的无蒂锯齿状息肉和 73%的增生性息肉被高估;P=0.008。根据形态,34%的有蒂息肉、49%的无蒂息肉和 61%的扁平息肉被高估;P=0.014。女性(54%)比男性(40%)更常见内镜高估(P=0.03),近端(56%)比远端(40%)更常见;P=0.02。误诊率不受内镜医生的协变量影响。
内镜和基于病理的息肉大小评估之间存在显著差异。近一半的内镜大小估计为≥1cm 的息肉在实际病理测量时低于这一阈值。